Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group-Reference-Cited by-同舟云学术

Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group

Published:2018-05-01 Issue:11 Volume:78 Page:775-789
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Miyahira Andrea K.¹^ORCID,Pienta Kenneth J.²^ORCID,Morris Michael J.³,Bander Neil H.⁴,Baum Richard P.⁵,Fendler Wolfgang P.⁶,Goeckeler William⁷,Gorin Michael A.²,Hennekes Hartwig⁸,Pomper Martin G.²,Sartor Oliver⁹,Tagawa Scott T.⁴,Williams Scott¹⁰,Soule Howard R.¹

Affiliation:

1. Prostate Cancer Foundation; Santa Monica California

2. The James Buchanan Brady Urological Institute and Department of Urology; Johns Hopkins University School of Medicine; Baltimore Maryland

3. Memorial Sloan Kettering Cancer Center; New York New York

4. Weill Cornell Medicine; New York New York

5. THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging; Zentralklinik Bad Berka; Bad Berka Germany

6. University of California; Los Angeles California

7. Bayer Healthcare; LLC; Whippany New Jersey

8. Bayer AG; Berlin Germany

9. Tulane University; New Orleans Louisiana

10. Peter MacCallum Cancer Centre; Melbourne Australia

Publisher

Wiley

Subject

Urology,Oncology

Reference88 articles.

1. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium;Liu;Cancer Res,1997

2. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen;Smith-Jones;Cancer Res,2000

3. 225Ac-PSMA-617 for PSMA-Targeted alpha-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer;Kratochwil;J Nucl Med,2016

4. Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer;Kasperzyk;Cancer Epidemiol Biomarkers Prev,2013

5. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer;Minner;Prostate,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer;Clinical Cancer Research;2024-04-09

2. Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer;Bioorganic Chemistry;2023-12

3. Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy;Cancers;2023-09-13

4. Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer;Molecules;2023-05-16

5. The Role of Radiolabeled Monoclonal Antibodies in Cancer Imaging and ADC Treatment;The Cancer Journal;2022-11